Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950103-10-000065)

Filing Details

Accession Number:: 0000950103-10-000065
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-01-11 12:00:00
Reporting Period:: 2010-01-07

Filing Date:: 2010-01-11
Accepted Time:: 2010-01-11 13:17:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1129425	Zymogenetics Inc	ZGEN	Biological Products, (No Disgnostic Substances) (2836)	911144498

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
353278	S A Nordisk Novo	Novo Alle Dk 2880 Bagsvaerd Denmark G7 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-01-07	1,250,000	$6.00	22,143,320	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Novo Nordisk A/S directly holds 22,143,320 shares of common stock of ZYMOGENETICS, INC. In addition, Novo A/S, the parent holding company of Novo Nordisk A/S, directly holds 866,541 shares of common stock of ZYMOGENETICS, INC.